Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Price & Analysis

Compare

0 Followers

AGARWALEYE Stock Chart & Stats

Day’s Range― - ―

52-Week Range₹327.40 - ₹493.35

Previous CloseN/A

VolumeN/A

Average Volume (3M)11.37K

Market Cap

₹145.56B

Enterprise ValueN/A

Total Cash (Recent Filing)₹4.91B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)―

Beta0.57

Next Earnings

Feb 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.00

Shares Outstanding316,158,360

10 Day Avg. Volume7,898

30 Day Avg. Volume11,372

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹478.00

Price Target Upside-1.39% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Dr. Agarwal's Health Care Ltd. News

Dr. Agarwal’s Health Care Expands Stake in Eye Hospital Subsidiary

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an announcement. Dr. Agarwal’s Health Care Ltd. has...

13h ago

Dr. Agarwal’s Health Care and Eye Hospital Announce Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has shared an announcement. Dr. Agarwal’s Health Care Limited and...

1M ago

Dr. Agarwal’s Health Care Announces Analyst Call on Proposed Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an update. Dr. Agarwal’s Health Care Limited has...

1M ago

Dr. Agarwal’s Health Care Ltd. Announces Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an announcement. Dr. Agarwal’s Health Care Ltd. has...

1M ago

Dr. Agarwal’s Health Care Releases Q1 Monitoring Report Post-IPO

An update from Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) is now available. Dr. Agarwal’s Health Care...

1M ago

Dr. Agarwal’s Health Care Limited Releases Q3 & 9M FY25 Earnings Call Transcript

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an update. Dr. Agarwal’s Health Care Limited has...

7M ago

AGARWALEYE FAQ

What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?

Dr. Agarwal's Health Care Ltd. lowest stock price was ₹327.40 and its highest was ₹493.35 in the past 12 months.

What is Dr. Agarwal's Health Care Ltd.’s market cap?

Dr. Agarwal's Health Care Ltd.’s market cap is ₹145.56B.

When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?

Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Feb 13, 2026 which is in 139 days.

How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?

Dr. Agarwal's Health Care Ltd. released its earnings results on Aug 12, 2025. The company reported ₹1 earnings per share for the quarter, beating the consensus estimate of ₹0.7 by ₹0.3.

Is Dr. Agarwal's Health Care Ltd. overvalued?

According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Dr. Agarwal's Health Care Ltd. pay dividends?

Dr. Agarwal's Health Care Ltd. does not currently pay dividends.

What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?

Dr. Agarwal's Health Care Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?

Dr. Agarwal's Health Care Ltd. has 316,158,360 shares outstanding.

What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?

Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1 in its last earnings report, beating expectations of ₹0.7. Following the earnings report the stock price went up 0.897%.

Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?

Currently, no hedge funds are holding shares in IN:AGARWALEYE

Company Description

Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Earnings & Revenues

Historic Earnings Reports

AGARWALEYE Stock 12 Month Forecast

Average Price Target

₹478.00

▼(-1.39% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"333":"₹333","406":"₹406","479":"₹479","369.5":"₹369.5","442.5":"₹442.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":478,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹478.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":478,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹478.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":478,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹478.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[333,369.5,406,442.5,479],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.2,410.8,416.4,422,427.59999999999997,433.2,438.8,444.4,450,455.6,461.2,466.8,472.4,{"y":478,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.2,410.8,416.4,422,427.59999999999997,433.2,438.8,444.4,450,455.6,461.2,466.8,472.4,{"y":478,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.2,410.8,416.4,422,427.59999999999997,433.2,438.8,444.4,450,455.6,461.2,466.8,472.4,{"y":478,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":394.75,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":394.75,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":402.15,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":453.05,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":365.8,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":334,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":405.2,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":405.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >